JP2009545534A5 - - Google Patents

Download PDF

Info

Publication number
JP2009545534A5
JP2009545534A5 JP2009522067A JP2009522067A JP2009545534A5 JP 2009545534 A5 JP2009545534 A5 JP 2009545534A5 JP 2009522067 A JP2009522067 A JP 2009522067A JP 2009522067 A JP2009522067 A JP 2009522067A JP 2009545534 A5 JP2009545534 A5 JP 2009545534A5
Authority
JP
Japan
Prior art keywords
alkyl
group
aryl
compound according
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009522067A
Other languages
English (en)
Japanese (ja)
Other versions
JP5357022B2 (ja
JP2009545534A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2007/001357 external-priority patent/WO2008014613A1/en
Publication of JP2009545534A publication Critical patent/JP2009545534A/ja
Publication of JP2009545534A5 publication Critical patent/JP2009545534A5/ja
Application granted granted Critical
Publication of JP5357022B2 publication Critical patent/JP5357022B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009522067A 2006-08-04 2007-08-01 多機能生物活性化合物 Expired - Fee Related JP5357022B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83542806P 2006-08-04 2006-08-04
US60/835,428 2006-08-04
PCT/CA2007/001357 WO2008014613A1 (en) 2006-08-04 2007-08-01 Multifunctional bioactive compounds

Publications (3)

Publication Number Publication Date
JP2009545534A JP2009545534A (ja) 2009-12-24
JP2009545534A5 true JP2009545534A5 (cg-RX-API-DMAC10.html) 2010-02-12
JP5357022B2 JP5357022B2 (ja) 2013-12-04

Family

ID=38996830

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009522067A Expired - Fee Related JP5357022B2 (ja) 2006-08-04 2007-08-01 多機能生物活性化合物

Country Status (10)

Country Link
US (2) US8637521B2 (cg-RX-API-DMAC10.html)
EP (1) EP2046778B1 (cg-RX-API-DMAC10.html)
JP (1) JP5357022B2 (cg-RX-API-DMAC10.html)
CN (1) CN101511823B (cg-RX-API-DMAC10.html)
AU (1) AU2007280995C1 (cg-RX-API-DMAC10.html)
BR (1) BRPI0714616A2 (cg-RX-API-DMAC10.html)
CA (1) CA2659875C (cg-RX-API-DMAC10.html)
EA (1) EA018548B1 (cg-RX-API-DMAC10.html)
MX (1) MX2009001351A (cg-RX-API-DMAC10.html)
WO (1) WO2008014613A1 (cg-RX-API-DMAC10.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
JP4681231B2 (ja) 2002-03-20 2011-05-11 マンカインド コーポレイション 吸入装置
ATE486064T1 (de) 2004-08-20 2010-11-15 Mannkind Corp Katalyse der diketopiperazinsynthese
HUE025151T2 (en) 2004-08-23 2016-01-28 Mannkind Corp Diceto-piperazine salts for drug delivery
MX373000B (es) 2005-09-14 2020-05-21 Mannkind Corp Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas.
CN104383546B (zh) 2006-02-22 2021-03-02 曼金德公司 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法
CA2571645A1 (en) * 2006-12-19 2008-06-19 Apotex Technologies Inc. Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
MY155524A (en) 2008-06-13 2015-10-30 Mannkind Corp A dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
EP2609954B1 (en) 2008-06-20 2021-12-29 MannKind Corporation An interactive apparatus for real-time profiling of inhalation efforts
TWI494123B (zh) 2008-08-11 2015-08-01 Mannkind Corp 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
CA2748490C (en) * 2008-12-29 2016-10-04 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
CA2749163A1 (en) 2009-01-14 2010-07-22 The Salk Institute For Biological Studies Methods for screening and compounds that protect against amyloid diseases
US8538707B2 (en) 2009-03-11 2013-09-17 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
AU2010259943C1 (en) 2009-06-12 2016-03-03 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
WO2011017799A1 (en) 2009-08-10 2011-02-17 Immunotech Developments Inc. Vaccine having a peptide adjuvant for eliciting a specific immune response to treat viral infection and other conditions
JP5784622B2 (ja) 2009-11-03 2015-09-24 マンカインド コーポレ−ション 吸入活動をシミュレートするための装置及び方法
RU2531455C2 (ru) 2010-06-21 2014-10-20 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
MX353285B (es) 2011-04-01 2018-01-05 Mannkind Corp Paquete de blister para cartuchos farmaceuticos.
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
HK1201475A1 (en) 2011-10-24 2015-09-04 Mannkind Corporation Methods and compositions for treating pain
HRP20181671T1 (hr) 2012-02-09 2018-12-14 Novus International, Inc. Heteroatom koji sadrži cikličke dimere
US9556167B2 (en) * 2012-05-02 2017-01-31 Yale University TLR-agonist-conjugated antibody recruiting molecules (TLR-ARMs)
PL2871973T3 (pl) 2012-07-12 2019-02-28 Novus International Inc. Kompozycje matrycy i warstwy do ochrony środków bioaktywnych
AU2013289957B2 (en) 2012-07-12 2017-02-23 Mannkind Corporation Dry powder drug delivery systems and methods
CA2879943C (en) * 2012-07-24 2021-08-31 Pharma Bio Llc Peptide-based compounds and uses thereof to treat .beta.-amyloid accumulation
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
BR112015023168B1 (pt) 2013-03-15 2021-08-10 Mannkind Corporation Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina
BR122019026637B1 (pt) 2013-07-18 2023-09-26 Mannkind Corporation Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco
CA2920488C (en) 2013-08-05 2022-04-26 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US10584306B2 (en) 2017-08-11 2020-03-10 Board Of Regents Of The University Of Oklahoma Surfactant microemulsions
CN110054619A (zh) * 2018-01-18 2019-07-26 西北农林科技大学 新型二酮哌嗪类组蛋白去乙酰化酶抑制剂
EP3843583A4 (en) * 2018-08-28 2022-03-30 Lingdong Technology (Beijing) Co., Ltd SELF-PROPELLED SYSTEMS WITH STOCK HOLDER

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4006261A (en) * 1973-09-28 1977-02-01 Firmenich S.A. Flavoring with mixtures of theobromine and cyclic dipeptides
US4289759A (en) * 1980-06-23 1981-09-15 Ortho Pharmaceutical Corporation Immunoregulatory diketopiperazine compounds
US4331595A (en) * 1980-06-23 1982-05-25 Ortho Pharmaceutical Corporation Immunoregulatory diketopiperazine compounds
GB8427735D0 (en) * 1984-11-02 1984-12-12 Fujisawa Pharmaceutical Co Piperazine compound
DE3909379A1 (de) * 1989-03-22 1990-09-27 Cassella Ag Thienylpiperazine, verfahren zu ihrer herstellung, ihre verwendung sowie diese enthaltende arzneimittel und deren herstellung
US5693338A (en) 1994-09-29 1997-12-02 Emisphere Technologies, Inc. Diketopiperazine-based delivery systems
US6331318B1 (en) 1994-09-30 2001-12-18 Emisphere Technologies Inc. Carbon-substituted diketopiperazine delivery systems
FR2677361A1 (fr) * 1991-06-04 1992-12-11 Adir Nouveaux peptides et pseudopeptides, derives de tachykinines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE69230500D1 (de) 1991-10-28 2000-02-03 Cytran Ltd Pharmazeutische Dipeptid Zusammensetzungen und Verwendungsmethoden.
US5352461A (en) * 1992-03-11 1994-10-04 Pharmaceutical Discovery Corporation Self assembling diketopiperazine drug delivery system
FR2722787B1 (fr) * 1994-07-21 1996-10-11 Univ Claude Bernard Lyon Composes a activite anthelminthique: dicetopiperazines, precurseurs et analogues
US6103699A (en) * 1996-06-07 2000-08-15 Immunotech Developments Inc. Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
US6060452A (en) 1996-03-13 2000-05-09 Cytran, Inc. Analogs of L-Glu-L-Trp having pharmacological activity
US5932579A (en) * 1996-06-18 1999-08-03 Affymax Technologies N.V. Collagenase-1 and stromelysin-1 inhibitors, pharmaceutical compositions comprising same and methods of their use
JPH10226615A (ja) * 1997-02-18 1998-08-25 Pola Chem Ind Inc アスパラギン酸フェニルアラニン環状ジペプタイド誘導体を含有する組成物
US7026322B2 (en) * 1998-11-12 2006-04-11 Nereus Pharmaceuticals, Inc. Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds
DE19937721A1 (de) 1999-08-10 2001-02-15 Max Planck Gesellschaft Neue Diketopiperazine
US6974478B2 (en) 1999-10-22 2005-12-13 Archus Orthopedics, Inc. Prostheses, systems and methods for replacement of natural facet joints with artificial facet joint surfaces
JP2001247566A (ja) * 2000-03-03 2001-09-11 Marine Biotechnol Inst Co Ltd 新規抗カビ活性物質およびその製造法
JP5048201B2 (ja) * 2000-08-04 2012-10-17 ディーエムアイ バイオサイエンシズ インコーポレイテッド ジケトピペラジン類の使用方法とジケトピペラジン類を含む組成物
US20030171379A1 (en) * 2001-12-28 2003-09-11 Jacobs Robert S. Methods of treating, preventing, or inhibiting inflammation with Mactanamide compounds
JP3846409B2 (ja) 2002-02-15 2006-11-15 株式会社村田製作所 弾性表面波装置、通信装置
CN102210852B (zh) 2003-05-15 2016-10-19 安皮奥制药股份有限公司 T-细胞介导的疾病的治疗
HUE025151T2 (en) * 2004-08-23 2016-01-28 Mannkind Corp Diceto-piperazine salts for drug delivery

Similar Documents

Publication Publication Date Title
TWI511972B (zh) 蛋白酶體抑制劑
US10208037B2 (en) Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds
JP2020063241A5 (cg-RX-API-DMAC10.html)
KR101474831B1 (ko) 프로테아좀 억제제
EP2721011B1 (en) Prostaglandin receptor ep2 antagonists, derivatives, compositions, and uses related thereto
JP2013523896A5 (cg-RX-API-DMAC10.html)
JP2009538348A5 (cg-RX-API-DMAC10.html)
KR20120060203A (ko) 신규한 오피오이드의 카바메이트 아미노산과 펩티드 프로드럭 및 그의 용도
Wu Strategies for designing synthetic immune agonists
WO2006033296A1 (ja) 新規ブロック共重合体、ミセル調製物及びそれを有効成分とする抗癌剤
JP6223995B2 (ja) カンプトテシン類と抗癌効果増強剤の結合した高分子化合物及びその用途
JP2013500304A5 (cg-RX-API-DMAC10.html)
CN102369204A (zh) 3-脱氮瓶菌素衍生物
JP2011523645A5 (cg-RX-API-DMAC10.html)
KR100199524B1 (ko) 엔-헤테로아릴-푸린-6-아민 및 이의 제조방법
JP2004511466A5 (cg-RX-API-DMAC10.html)
RU2016122731A (ru) Функционализированные и замещенные индолы в качестве противораковых агентов
JP2014532728A5 (cg-RX-API-DMAC10.html)
US20200000810A1 (en) Brk inhibitory compound
CN107001354A (zh) 组蛋白去乙酰酶抑制剂
CN110582300A (zh) 肿瘤免疫治疗性治疗方法
JP2024540030A (ja) 修飾インドール化合物
ES2746105T3 (es) Profármacos de 5-aza-pirimidina sililada útiles para tratar el cáncer
KR0130977B1 (ko) 항종양제로서 폴리아민 유도체
US20080027094A1 (en) Tropane Compounds and Pharmaceutical Compositions Comprising the Same as an Active Ingredient